CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 16,868 | -95.3% | 0.00% | -100.0% |
| Q3 2022 | $60,000 | -37.5% | 362,544 | +286.9% | 0.00% | 0.0% |
| Q3 2021 | $96,000 | -27.8% | 93,705 | +29.1% | 0.00% | 0.0% |
| Q2 2021 | $133,000 | +77.3% | 72,601 | +91.0% | 0.00% | 0.0% |
| Q1 2021 | $75,000 | -21.1% | 38,005 | +234.6% | 0.00% | -50.0% |
| Q2 2020 | $95,000 | +61.0% | 11,359 | +4.2% | 0.00% | +100.0% |
| Q4 2019 | $59,000 | -55.3% | 10,897 | -42.9% | 0.00% | -80.0% |
| Q2 2019 | $132,000 | – | 19,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |